This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovations by Shung-Tai Ho
Introduction
Shung-Tai Ho is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in pain management. His innovative work has led to the development of a unique long-acting analgesic agent.
Latest Patents
One of Shung-Tai Ho's key patents is titled "Long analgesic acting nalbuphine polyester derivative and method of use." This patent describes a novel nalbuphine polyester derivative, represented as R—[CO-NAL], where n is an integer from 2-4. The R group can be a saturated or unsaturated, substituted or unsubstituted, aliphatic or aromatic group containing 1 to 40 carbon atoms. The process for producing this derivative involves esterifying nalbuphine with a fatty acid or a halogen compound of the fatty acid along with an acid anhydride. The resulting pharmaceutical composition can be administered to treat pain effectively.
Career Highlights
Shung-Tai Ho has achieved recognition for his innovative approaches in the pharmaceutical industry. His work focuses on creating effective pain relief solutions that can significantly improve the quality of life for patients. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medical science.
Collaborations
Shung-Tai Ho has collaborated with notable colleagues such as Oliver Yoa-Pu Hu and Fangchen Lee. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in their field.
Conclusion
Shung-Tai Ho's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his commitment to improving pain management. His work exemplifies the impact of inventive thinking in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile